| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Health Sciences | 82 | 1.8K | 107.1K |
2 | Engineering | 77 | 1.9K | 76.5K |
3 | Education | 30 | 186 | 7.3K |
4 | Business | 25 | 46 | 2.9K |
5 | Arts | 12 | 38 | 1.1K |
Università Campus Bio-Medico
×
17.9K
Publications
1.2M
Citations
| Year | Citations | |
|---|---|---|
2021 | 2.5K | |
2010 | 2.1K | |
2004 | 1.4K | |
2007 | 1.2K | |
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti, Phase 3Gastrointestinal OncologyMedicinePathologyColorectal Cancer | 2015 | 1.1K |
2020 | 1K | |
2007 | 809 | |
2020 | 760 | |
2022 | 722 | |
2009 | 656 |
Page 1
Page 1